4 ms·
From the first post: "In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assa
by mrfinn 5y ago
From the first post:
"In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test. CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses."
TL;DR
"Move on from the current PCR test. We encourage laboratories to consider adoption of a method that can facilitate detection and differentiation between SARS-Cov-2 and influenza viruses".
It's so clear that at this point I won't add anything more to conversation.
- TYPE_FASTER 5y agoAs the CDC points out in the clarification, the PCR test only detects SARS-CoV-2, not influenza: "The CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel does not confuse influenza with SARS-CoV-2." Suggesting that labs use testing methods that can differentiate between SARS-CoV-2 and influenza viruses does not equate to PCR tests not being able to differentiate between the two.
- pwinnski 5y agoI am discontinuing the ingestion of Cherry Vanilla Coke Zero. I will need to begin my transition to another calorie-free carbonated beverage. I have been encouraged to consider adoption of a calorie-free carbonated beverage that quenches my thirst. Am I saying that Cherry Vanilla Coke Zero does not quench my thirst? Because it does. No, the statements above only suggest that when evaluating replacements for Cherry Vanilla Coke Zero, I should choose a replacement that meets all of the same requirements. You are clearly not the only person confused by the language, which is why they published a clarification. I will leave it as an exercise for the reader to determine whether such confusion is natural or should have been anticipated.